Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery
Giulia Angelini(Università Cattolica del Sacro Cuore), Royce P Vincent(Hammersmith Hospital), Matteo Garcovich(Agostino Gemelli University Polyclinic), Laura Riccardi(Università Cattolica del Sacro Cuore), Tracey Mare(King's College Hospital NHS Foundation Trust), Ornella Verrastro(Agostino Gemelli University Polyclinic), Geltrude Mingrone(University of the Sacred Heart), Maurizio Pompili, Simona Panunzi(Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti), James Luxton(King's College Hospital NHS Foundation Trust), Carel W. le Roux(University College Dublin), Sara Russo(Università Cattolica del Sacro Cuore), Marco Raffaelli(Università Cattolica del Sacro Cuore)
Cited by 2
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
|New England Journal of Medicine|2003|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k